{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:12:32Z","timestamp":1788415952940,"version":"build-2803163510"},"reference-count":88,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008108","name":"Taipei Tzu Chi Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Breast cancer metastasis remains the leading cause of disease-related mortality despite major advances in systemic therapy. Increasing evidence indicates that the circadian\u2013melatonin axis may influence metastatic progression by coordinating endocrine signaling, metabolism, immune responses, and tumor cell plasticity. In this review, we summarize current epidemiological, mechanistic, and translational evidence linking circadian disruption and melatonin to breast cancer metastasis. We discuss how core circadian clock genes and melatonin signaling may influence epithelial\u2013mesenchymal transition, cancer stemness, circulating tumor cell dissemination, tumor metabolism, and immune remodeling. We further highlight the emerging potential roles of melatonin in shaping adipocyte\u2013tumor crosstalk and organ-specific metastatic niches, including bone, lung, liver, and brain, where tissue-specific interactions may influence metastatic colonization. Finally, we discuss the clinical potential of circadian chronotherapy, adjuvant melatonin, and circadian biomarker-guided precision medicine. Although substantial experimental evidence supports the anti-metastatic properties of the circadian\u2013melatonin axis, clinical translation remains limited by context-dependent biological effects and the lack of chronobiology-informed trials. Future studies integrating circadian biomarkers with optimized treatment timing and modern systemic therapies may facilitate precision strategies for preventing and treating metastatic breast cancer.<\/jats:p>","DOI":"10.3389\/fendo.2026.1941609","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:14:52Z","timestamp":1788412492000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The circadian\u2013melatonin axis in breast cancer metastasis: molecular mechanisms, organ-specific metastatic niches, and therapeutic opportunities"],"prefix":"10.3389","volume":"17","author":[{"given":"Ching-Hsiang","family":"Wang","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Taoyuan Armed Forces General Hospital","place":["Taoyuan, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kian-Hwee","family":"Chong","sequence":"additional","affiliation":[{"name":"Division of General Surgery, Department of Surgery, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation","place":["New Taipei, Taiwan"]},{"name":"School of Medicine, Tzu Chi University","place":["Hualien, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Feng","family":"Cheng","sequence":"additional","affiliation":[{"name":"School of Medicine, Tzu Chi University","place":["Hualien, Taiwan"]},{"name":"Department of Pediatrics, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation","place":["New Taipei City, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Jen","family":"Chang","sequence":"additional","affiliation":[{"name":"Division of General Surgery, Department of Surgery, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation","place":["New Taipei, Taiwan"]},{"name":"School of Medicine, Tzu Chi University","place":["Hualien, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Wang","family":"Tsai","sequence":"additional","affiliation":[{"name":"Department of Research, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation","place":["New Taipei City, Taiwan"]},{"name":"Department of Nursing, Cardinal Tien Junior College of Healthcare and Management","place":["New Taipei City, Taiwan"]},{"name":"Department of Post-Baccalaureate Nursing, Tzu Chi University","place":["Hualien, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-024-1058-6","article-title":"Disparities in 36 cancers across 185 countries: secondary analysis of global cancer statistics","volume":"18","author":"Li","year":"2024","journal-title":"Front Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04875-y","article-title":"The metastatic spread of breast cancer accelerates during sleep","volume":"607","author":"Diamantopoulou","year":"2022","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(07)70373-x","article-title":"Carcinogenicity of shift-work, painting, and fire-fighting","volume":"8","author":"Straif","year":"2007","journal-title":"Lancet Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.lfs.2017.02.008","article-title":"Association between light at night, melatonin secretion, sleep deprivation, and the internal clock: health impacts and mechanisms of circadian disruption","volume":"173","author":"Touitou","year":"2017","journal-title":"Life Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s40572-017-0155-y","article-title":"Night shift work and risk of breast cancer","volume":"4","author":"Hansen","year":"2017","journal-title":"Curr Environ Health Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-05-1945","article-title":"Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats","volume":"65","author":"Blask","year":"2005","journal-title":"Cancer Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-13-3156","article-title":"Circadian and melatonin disruption by exposure to light at night drives intrinsic resistance to tamoxifen therapy in breast cancer","volume":"74","author":"Dauchy","year":"2014","journal-title":"Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2174\/1871520615666150511094201","article-title":"Melatonin regulates angiogenic factors under hypoxia in breast cancer cell lines","volume":"16","author":"Jardim-Perassi","year":"2016","journal-title":"Anti-Cancer Agents Med Chem"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12116","article-title":"Melatonin effects on bone: potential use for the prevention and treatment for osteopenia, osteoporosis, and periodontal disease and for use in bone-grafting procedures","volume":"56","author":"Maria","year":"2014","journal-title":"J Pineal Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41580-019-0179-2","article-title":"Molecular mechanisms and physiological importance of circadian rhythms","volume":"21","author":"Patke","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s12576-018-0597-5","article-title":"The mammalian circadian system: a hierarchical multi-oscillator structure for generating circadian rhythm","volume":"68","author":"Honma","year":"2018","journal-title":"J Physiol Sci"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2311854121","article-title":"Tumor circadian clock strength influences metastatic potential and predicts patient prognosis in luminal A breast cancer","volume":"121","author":"Li","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1615\/critrevoncog.v13.i4.30","article-title":"Light at night, chronodisruption, melatonin suppression, and cancer risk: a review","volume":"13","author":"Reiter","year":"2007","journal-title":"Crit Rev Oncog"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2012.01.004","article-title":"Melatonin membrane receptors in peripheral tissues: distribution and functions","volume":"351","author":"Slominski","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1080\/03602532.2024.2305764","article-title":"Melatonin in cancer biology: pathways, derivatives, and the promise of targeted delivery","volume":"56","author":"Yi","year":"2024","journal-title":"Drug Metab Rev"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18040843","article-title":"Melatonin, a full service anti-cancer agent: inhibition of initiation, progression and metastasis","volume":"18","author":"Reiter","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B18","volume-title":"Night shift work","year":"2020"},{"key":"B19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jncc.2024.07.004","article-title":"Night shift work and breast cancer risk - 2023 update of epidemiologic evidence","volume":"5","author":"Hansen","year":"2025","journal-title":"J Natl Cancer Cent"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.23938\/assn.1149","article-title":"Nightshift work and risk of breast and prostate cancer: a systematic review and meta-analysis, 2012-2023","volume":"48","author":"Soler-Sana","year":"2025","journal-title":"Sist Sanit Navar"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-022-06792-0","article-title":"Circadian rhythm disrupting behaviours and cancer outcomes in breast cancer survivors: a systematic review","volume":"198","author":"D'Cunha","year":"2023","journal-title":"Breast Cancer Res Treat"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1186\/1740-3391-6-4","article-title":"Period-2: a tumor suppressor gene in breast cancer","volume":"6","author":"Xiang","year":"2008","journal-title":"J Circadian Rhythms"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-008-0133-z","article-title":"Down regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm","volume":"117","author":"Yang","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvad057","article-title":"The circadian protein BMAL1 supports endothelial cell cycle during angiogenesis","volume":"119","author":"Astone","year":"2023","journal-title":"Cardiovasc Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-026-01788-8","article-title":"BMAL1 silencing as a promising chemosensitizing strategy for triple-negative breast cancer","author":"Wang","year":"2026","journal-title":"Acta Pharmacol Sin"},{"key":"B26","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00432-024-05917-w","article-title":"Circadian rhythms and breast cancer: from molecular level to therapeutic advancements","volume":"150","author":"Li","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/pai.0000000000000788","article-title":"Role of melatonin in breast carcinoma: correlation of expression patterns of melatonin-1 receptor with estrogen, progesterone, and HER2 receptors","volume":"28","author":"Goyal","year":"2020","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1309\/1t4v-ct1g-ubjp-3ehp","article-title":"Differential expression of high-affinity melatonin receptors (MT1) in normal and Malignant human breast tissue","volume":"118","author":"Dillon","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/s0304-3835(01)00873-4","article-title":"Involvement of the mt1 melatonin receptor in human breast cancer","volume":"179","author":"Ram","year":"2002","journal-title":"Cancer Lett"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605336","article-title":"Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells","volume":"101","author":"Martinez-Campa","year":"2009","journal-title":"Br J Cancer"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-012-1953-4","article-title":"Melatonin suppresses aromatase expression and activity in breast cancer associated fibroblasts","volume":"132","author":"Knower","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"B32","article-title":"Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events","volume":"59","author":"Blask","year":"1999","journal-title":"Cancer Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102776","article-title":"Light exposure at night disrupts host\/cancer circadian regulatory dynamics: impact on the Warburg effect, lipid signaling and tumor growth prevention","volume":"9","author":"Blask","year":"2014","journal-title":"PloS One"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-011-1884-5","article-title":"Melatonin pathway genes and breast cancer risk among Chinese women","volume":"132","author":"Deming","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.70086","article-title":"Evaluating the role of PD1 and MTNR1B gene variants in breast cancer susceptibility: a case-control study in Bangladesh","volume":"39","author":"Jamil","year":"2025","journal-title":"J Clin Lab Anal"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34047","article-title":"The role of MTNR1B polymorphism on circadian rhythm-related cancer: a UK Biobank cohort study","volume":"151","author":"Wu","year":"2022","journal-title":"Int J Cancer"},{"key":"B37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4068\/cmj.2025.61.2.63","article-title":"Melatonin and breast cancer: a review article","volume":"61","author":"Motehaver","year":"2025","journal-title":"Chonnam Med J"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010438","article-title":"Melatonin as an oncostatic molecule based on its anti-aromatase role in breast cancer","volume":"22","author":"Jin","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m403140200","article-title":"Melatonin, an endogenous-specific inhibitor of estrogen receptor alpha via calmodulin","volume":"279","author":"del Rio","year":"2004","journal-title":"J Biol Chem"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2794","article-title":"Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway","volume":"12","author":"Mao","year":"2010","journal-title":"Breast Cancer Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.70010","article-title":"Effects of melatonin on the expression of invasion-related markers (MMP2 and MMP9) in breast cancer cells","volume":"126","author":"Ghadimi","year":"2025","journal-title":"J Cell Biochem"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1210\/me.2012-1071","article-title":"Circadian gating of epithelial-to-mesenchymal transition in breast cancer cells via melatonin-regulation of GSK3beta","volume":"26","author":"Mao","year":"2012","journal-title":"Mol Endocrinol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1515\/hmbci-2023-0082","article-title":"The evaluation of melatonin and EGF interaction on breast cancer metastasis","volume":"45","author":"Akbarzadeh","year":"2024","journal-title":"Horm Mol Biol Clin Investig"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150407","article-title":"Effect of melatonin in epithelial mesenchymal transition markers and invasive properties of breast cancer stem cells of canine and human cell lines","volume":"11","author":"Goncalves Ndo","year":"2016","journal-title":"PloS One"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.27678","article-title":"Melatonin inhibits breast cancer cell invasion through modulating DJ-1\/KLF17\/ID-1 signaling pathway","volume":"120","author":"El-Sokkary","year":"2019","journal-title":"J Cell Biochem"},{"key":"B46","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1038\/s41467-020-16890-6","article-title":"Chronic circadian disruption modulates breast cancer stemness and immune microenvironment to drive metastasis in mice","volume":"11","author":"Hadadi","year":"2020","journal-title":"Nat Commun"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16050956","article-title":"Melatonin and its role in the epithelial-to-mesenchymal transition (EMT) in cancer","volume":"16","author":"Martinez-Campa","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116960","article-title":"Boosting immune system against cancer by melatonin: a mechanistic viewpoint","volume":"238","author":"Mortezaee","year":"2019","journal-title":"Life Sci"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115649","article-title":"Melatonin downregulates PD-L1 expression and modulates tumor immunity in KRAS-mutant non-small cell lung cancer","volume":"22","author":"Chao","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15338","article-title":"Melatonin inhibits EMT and PD-L1 expression through the ERK1\/2\/FOSL1 pathway and regulates anti-tumor immunity in HNSCC","volume":"113","author":"Luo","year":"2022","journal-title":"Cancer Sci"},{"key":"B51","doi-asserted-by":"publisher","first-page":"8451","DOI":"10.1038\/s41598-025-93486-4","article-title":"Melatonin suppresses PD-L1 expression and exerts antitumor activity in hepatocellular carcinoma","volume":"15","author":"Guo","year":"2025","journal-title":"Sci Rep"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2023.111917","article-title":"Melatonin enhances anti-tumor immunity by targeting macrophages PD-L1 via exosomes derived from gastric cancer cells","author":"Wang","year":"2023","journal-title":"Mol Cell Endocrinol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.19642","article-title":"Exosomes from melatonin treated hepatocellularcarcinoma cells alter the immunosupression status through STAT3 pathway in macrophages","volume":"13","author":"Cheng","year":"2017","journal-title":"Int J Biol Sci"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-019-03438-1","article-title":"Melatonin inhibits Warburg-dependent cancer by redirecting glucose oxidation to the mitochondria: a mechanistic hypothesis","volume":"77","author":"Reiter","year":"2020","journal-title":"Cell Mol Life Sci"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12755","article-title":"Melatonin inhibits lung cancer development by reversing the Warburg effect via stimulating the SIRT3\/PDH axis","volume":"71","author":"Chen","year":"2021","journal-title":"J Pineal Res"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-10-3323","article-title":"Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion","volume":"71","author":"Dirat","year":"2011","journal-title":"Cancer Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079x.2011.00940.x","article-title":"Melatonin interferes in the desmoplastic reaction in breast cancer by regulating cytokine production","volume":"52","author":"Alvarez-Garcia","year":"2012","journal-title":"J Pineal Res"},{"key":"B58","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1600-079X.2011.00911.x","article-title":"Melatonin promotes differentiation of 3T3-L1 fibroblasts","volume":"52","author":"Gonzalez","year":"2012","journal-title":"J Pineal Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqab057","article-title":"Melatonin inhibits osteoclastogenesis and bone loss in ovariectomized mice by regulating PRMT1-mediated signaling","volume":"162","author":"Choi","year":"2021","journal-title":"Endocrinology"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27020501","article-title":"Melatonin attenuates RANKL-induced osteoclastogenesis via inhibition of Atp6v0d2 and DC-STAMP through MAPK and NFATc1 signaling pathways","volume":"27","author":"Kim","year":"2022","journal-title":"Molecules"},{"key":"B61","doi-asserted-by":"publisher","first-page":"5716","DOI":"10.1038\/s41598-017-06304-x","article-title":"Melatonin promotes osteoblast differentiation by regulating Osterix protein stability and expression","volume":"7","author":"Han","year":"2017","journal-title":"Sci Rep"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.17440","article-title":"Melatonin inhibits osteoclastogenesis via RANKL\/OPG suppression mediated by Rev-Erbalpha in osteoblasts","volume":"26","author":"Tian","year":"2022","journal-title":"J Cell Mol Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-01613-4","article-title":"Melatonin interrupts osteoclast functioning and suppresses tumor-secreted RANKL expression: implications for bone metastases","volume":"40","author":"Liu","year":"2021","journal-title":"Oncogene"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13796","article-title":"GALNT14 promotes lung-specific breast cancer metastasis by modulating self-renewal and interaction with the lung microenvironment","volume":"7","author":"Song","year":"2016","journal-title":"Nat Commun"},{"key":"B65","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/jpi.12270","article-title":"Melatonin decreases breast cancer metastasis by modulating Rho-associated kinase protein-1 expression","volume":"60","author":"Borin","year":"2016","journal-title":"J Pineal Res"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1177\/09603271211002883","article-title":"Melatonin decreases metastasis, primary tumor growth and angiogenesis in a mice model of breast cancer","volume":"40","author":"Karadas","year":"2021","journal-title":"Hum Exp Toxicol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.11.037","article-title":"Emerging biological principles of metastasis","volume":"168","author":"Lambert","year":"2017","journal-title":"Cell"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/nature15756","article-title":"Tumour exosome integrins determine organotropic metastasis","volume":"527","author":"Hoshino","year":"2015","journal-title":"Nature"},{"key":"B69","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41421-025-00819-8","article-title":"Breast cancer induces CD62L(+) Kupffer cells via DMBT1 to promote neutrophil extracellular trap formation and liver metastasis","volume":"11","author":"Tian","year":"2025","journal-title":"Cell Discov"},{"key":"B70","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1093\/neuonc\/noaa285","article-title":"The incidence of brain metastases among patients with metastatic breast cancer: a systematic review and meta-analysis","volume":"23","author":"Kuksis","year":"2021","journal-title":"Neuro Oncol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/nature08021","article-title":"Genes that mediate breast cancer metastasis to the brain","volume":"459","author":"Bos","year":"2009","journal-title":"Nature"},{"key":"B72","doi-asserted-by":"publisher","first-page":"6716","DOI":"10.1038\/ncomms7716","article-title":"Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier","volume":"6","author":"Tominaga","year":"2015","journal-title":"Nat Commun"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/920509","article-title":"Blood-brain barrier integrity and breast cancer metastasis to the brain","volume":"2011","author":"Arshad","year":"2010","journal-title":"Patholog Res Int"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.18632\/aging.102537","article-title":"Melatonin protects blood-brain barrier integrity and permeability by inhibiting matrix metalloproteinase-9 via the NOTCH3\/NF-kappaB pathway","volume":"11","author":"Qin","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2024.101158","article-title":"Melatonin and brain barriers: The protection conferred by melatonin to the blood-brain barrier and blood-cerebrospinal fluid barrier","volume":"75","author":"Mineiro","year":"2024","journal-title":"Front Neuroendocrinol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41523-025-00762-7","article-title":"A pragmatic, multicenter, randomized trial comparing morning versus evening dosing of adjuvant endocrine therapy (REaCT-CHRONO Study)","volume":"11","author":"Savard","year":"2025","journal-title":"NPJ Breast Cancer"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1093\/jrr\/rrt141","article-title":"Comparison of acute skin reaction following morning versus late afternoon radiotherapy in patients with breast cancer who have undergone curative surgical resection","volume":"55","author":"Noh","year":"2014","journal-title":"J Radiat Res"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000027155","article-title":"A protective effect of morning radiotherapy on acute skin toxicity in patients with breast cancer: a prospective cohort study","volume":"100","author":"Fuzissaki","year":"2021","journal-title":"Med (Baltimore)"},{"key":"B79","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.clon.2018.10.001","article-title":"Genetic variants predict optimal timing of radiotherapy to reduce side-effects in breast cancer patients","volume":"31","author":"Johnson","year":"2019","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104269","article-title":"Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort","volume":"84","author":"Webb","year":"2022","journal-title":"EBioMedicine"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-012-1828-8","article-title":"The efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trials","volume":"69","author":"Wang","year":"2012","journal-title":"Cancer Chemother Pharmacol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1177\/1534735411425484","article-title":"Melatonin as adjuvant cancer care with and without chemotherapy: a systematic review and meta-analysis of randomized trials","volume":"11","author":"Seely","year":"2012","journal-title":"Integr Cancer Ther"},{"key":"B83","doi-asserted-by":"publisher","first-page":"CD010145","DOI":"10.1002\/14651858.cd010145.pub2","article-title":"Melatonin in cancer treatment","volume":"4","author":"Yu","year":"2025","journal-title":"Cochrane Database Syst Rev"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15061616","article-title":"Therapeutic potential of melatonin counteracting chemotherapy-induced toxicity in breast cancer patients: a systematic review","volume":"15","author":"Ramos","year":"2023","journal-title":"Pharmaceutics"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2015.10.015","article-title":"Melatonin enhancement of the radiosensitivity of human breast cancer cells is associated with the modulation of proteins involved in estrogen biosynthesis","volume":"370","author":"Alonso-Gonzalez","year":"2016","journal-title":"Cancer Lett"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyad250","article-title":"Melatonin supplementation for cancer-related fatigue in patients with early stage breast cancer receiving radiotherapy: a double-blind placebo-controlled trial","volume":"29","author":"Mukhopadhyay","year":"2024","journal-title":"Oncologist"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1177\/15347354251371705","article-title":"Efficacy of melatonin in alleviating radiotherapy-induced fatigue, anxiety, and depression in breast cancer patients: a randomized, triple-blind, placebo-controlled trial","volume":"24","author":"Sadeghi Yazdankhah","year":"2025","journal-title":"Integr Cancer Ther"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105141","article-title":"Association between endocrine adjuvant therapy intake timing and disease-free survival in patients with high-risk early breast cancer: results of a sub-study of the UCBG- UNIRAD trial","volume":"104","author":"Giacchetti","year":"2024","journal-title":"EBioMedicine"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1941609\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:14:53Z","timestamp":1788412493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1941609\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":88,"alternative-id":["10.3389\/fendo.2026.1941609"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1941609","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"article-number":"1941609"}}